Press Releases

2010

June 1, 2010 - DiscoveRx Corporation Expands its GPCR Technology Portfolio to Include Advanced Technologies
that Facilitate Lead Optimization and SAR

January 13, 2010 - DiscoveRx adds new products and services to augment its comprehensive portfolio of the largest
non-force coupled GPCR assays and reagents

January 11, 2010 - DiscoveRx Corp. & Jubilant Biosys Limited announce Co-Marketing Agreement for Screening Services

2009

October 20, 2009 - Evotec Signs Agreement with DiscoveRx Corporation to Support High Throughput Screening Services

October 8, 2009 - DiscoveRx and BioFocus announce a co-marketing agreement for GPCR screening

October 1, 2009 - DiscoveRx signs a worldwide agreement with GlaxoSmithKline (GSK) that allows GSK, access to PathHunter™ ß-Arrestin cell lines and reagents for GPCR screening

September 23, 2009 - Industry and academia team up in three-way collaboration to identify natural substances that can bind to orphan G protein-coupled receptors. Findings could lead to new targets for drug discovery

January 13, 2009 - DiscoveRx Adds New Products and Services to Augment its Comprehensive Portfolio of
the Largest Non-force Coupled GPCR Assays and Reagents

2008

November 17, 2008 - Frost & Sullivan Recognizes Excellence in Healthcare Innovation Distinguished Companies to Usher in New Era in Healthcare

September 10, 2008 - Frost & Sullivan Recognizes DiscoveRx with Product Line Strategy Award

March 03, 2008 - DiscoveRx Corporation Develops a Highly Sensitive and Quantitative Fluorescence Assay for PI3 Kinase

February 06, 2008 - DiscoveRx Corporation Signs Agreement with Cosmo Bio Co., Ltd. for Drug Discovery Screening Services Representation in Japan